<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Anti‐inflammatory treatment for carditis in acute rheumatic fever - Cilliers, A - 2015 | Cochrane Library</title> <meta content="Anti‐inflammatory treatment for carditis in acute rheumatic fever - Cilliers, A - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003176.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Anti‐inflammatory treatment for carditis in acute rheumatic fever - Cilliers, A - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003176.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003176.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Anti‐inflammatory treatment for carditis in acute rheumatic fever" name="citation_title"/> <meta content="Antoinette Cilliers" name="citation_author"/> <meta content="Chris Hani Baragwanath Hospital" name="citation_author_institution"/> <meta content="amcilliers@icon.co.za" name="citation_author_email"/> <meta content="Alma J Adler" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="Haroon Saloojee" name="citation_author"/> <meta content="University of the Witwatersrand" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD003176.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/05/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003176.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003176.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003176.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents [*therapeutic use]; Aspirin [therapeutic use]; Immunoglobulins, Intravenous [therapeutic use]; Myocarditis [*drug therapy]; Randomized Controlled Trials as Topic; Rheumatic Heart Disease [*drug therapy]; Steroids [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003176.pub3&amp;doi=10.1002/14651858.CD003176.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="urvLIhM4";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003176\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003176\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003176.pub3",title:"Anti\\u2010inflammatory treatment for carditis in acute rheumatic fever",firstPublishedDate:"May 28, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003176.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003176.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003176.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003176.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003176.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003176.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003176.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003176.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003176.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003176.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10449 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003176.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/appendices#CD003176-sec-0084"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/table_n/CD003176StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/table_n/CD003176StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Anti‐inflammatory treatment for carditis in acute rheumatic fever</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#CD003176-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Antoinette Cilliers</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#CD003176-cr-0003">Alma J Adler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information#CD003176-cr-0004">Haroon Saloojee</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information/en#CD003176-sec-0104">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 May 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003176.pub3">https://doi.org/10.1002/14651858.CD003176.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003176-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003176-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003176-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003176-abs-0009">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003176-abs-0001" lang="en"> <section id="CD003176-sec-0001"> <h3 class="title" id="CD003176-sec-0001">Background</h3> <p>Rheumatic heart disease remains an important cause of acquired heart disease in developing countries. Although prevention of rheumatic fever and management of recurrences have been well established, optimal management of active rheumatic carditis remains unclear. This is an update of a review published in 2003, and previously updated in 2009 and 2012. </p> </section> <section id="CD003176-sec-0002"> <h3 class="title" id="CD003176-sec-0002">Objectives</h3> <p>To assess the effects, both harmful and beneficial, of anti‐inflammatory agents such as aspirin, corticosteroids and other drugs in preventing or reducing further valvular damage in patients with acute rheumatic fever. </p> </section> <section id="CD003176-sec-0003"> <h3 class="title" id="CD003176-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (2013, Issue 9 of 12), MEDLINE (Ovid, 1948 to 2013 October Week 1), EMBASE (Ovid, 1980 to 2013 Week 41) and Latin American Caribbean Health Sciences Literature (LILACS) (1982 to 17 October 2013). We last searched Index Medicus (1950 to April 2001) in 2001. We checked reference lists of identified studies and applied no language restrictions. </p> </section> <section id="CD003176-sec-0004"> <h3 class="title" id="CD003176-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing anti‐inflammatory agents (e.g. aspirin, steroids, immunoglobulins, pentoxifylline) versus placebo or controls, or comparing any of the anti‐inflammatory agents versus one another, in adults and children with acute rheumatic fever diagnosed according to Jones, or modified Jones, criteria. The presence of cardiac disease one year after treatment was the major outcome criterion selected. </p> </section> <section id="CD003176-sec-0005"> <h3 class="title" id="CD003176-sec-0005">Data collection and analysis</h3> <p>Two review authors extracted data and assessed risk of bias using the methodology outlined in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i>. Standard methodological procedures as expected by The Cochrane Collaboration were used. </p> </section> <section id="CD003176-sec-0006"> <h3 class="title" id="CD003176-sec-0006">Main results</h3> <p>No new studies were included in this update. Eight randomised controlled trials involving 996 people were selected for inclusion in the review. Researchers compared several steroidal agents such as corticotrophin, cortisone, hydrocortisone, dexamethasone, prednisone and intravenous immunoglobulin versus aspirin, placebo or no treatment. Six trials were conducted between 1950 and 1965; one was done in 1990 and the final study was published in 2001. Overall there were no observed significant differences in risk of cardiac disease at one year between corticosteroid‐treated and aspirin‐treated groups (six studies, 907 participants, risk ratio 0.87, 95% confidence interval 0.66 to 1.15). Similarly, use of prednisone (two studies, 212 participants, risk ratio 1.13, 95% confidence interval 0.52 to 2.45) compared with aspirin did not reduce the risk of heart disease after one year. Investigators in five studies did not report adverse events. The three studies reporting on adverse events reported substantial adverse events. However, all results should be interpreted with caution because of the age of the studies and the substantial risk of bias. </p> </section> <section id="CD003176-sec-0007"> <h3 class="title" id="CD003176-sec-0007">Authors' conclusions</h3> <p>Little evidence of benefit was found when corticosteroids or intravenous immunoglobulins were used to reduce the risk of heart valve lesions in patients with acute rheumatic fever. The antiquity of most of the trials restricted adequate statistical analysis of the data and acceptable assessment of clinical outcomes by current standards. In addition, risk of bias was substantial, so results should be viewed with caution. New randomised controlled trials in patients with acute rheumatic fever are warranted to assess the effects of corticosteroids such as oral prednisone and intravenous methylprednisolone and the effects of other new anti‐inflammatory agents. Advances in echocardiography will allow more objective and precise assessments of cardiac outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003176-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003176-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD003176-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD003176-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003176-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD003176-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003176-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003176-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003176-abs-0002" lang="en"> <h3>Anti‐inflammatory treatment in the form of corticosteroids and immunotherapy to prevent heart damage resulting from rheumatic fever </h3> <p>This is an update of a review published in 2003 and previously updated in 2009 and 2012. For this latest update, the search was rerun on 17 October 2013, and no new studies were found. Rheumatic fever is a late complication of a type of throat infection caused by streptococcal bacteria. It is an immune system disease that can lead to inflammatory disease of the heart (carditis), joints, brain and skin. Carditis can cause heart failure and death. Various anti‐inflammatory drugs have been used to treat carditis, including corticosteroids, aspirin and immunoglobulins (immune therapy using antibodies). No new trials were identified in this update. This review includes eight trials with 996 participants. Evidence shows little effect of corticosteroids over aspirin in preventing cardiac disease after one year (six studies, 907 participants, risk ratio 0.87, 95% confidence interval 0.66 to 1.15). Several steroidal agents such as corticotrophin, cortisone, hydrocortisone and dexamethasone were compared with aspirin before 1966, and prednisone and immunoglobulins were compared with placebo in studies from 1990 and 2001, respectively. Most studies did not report on adverse events, but those that did reported complications due to corticosteroids including weight gain, enlarged facial features and acne. Trials were generally old (six of the eight trials were conducted between 1955 and 1965), small and of poor quality and had high risk of bias. For this reason, results should be interpreted with caution. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003176-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003176-sec-0079"></div> <h3 class="title" id="CD003176-sec-0080">Implications for practice</h3> <section id="CD003176-sec-0080"> <p>Up to now, no evidence provided by the reviewed studies has supported the benefit of using anti‐inflammatory drugs such as corticosteroids, intravenous immunoglobulins or aspirin to prevent or reduce cardiac disease in patients presenting with acute rheumatic fever. However, all findings should be interpreted cautiously, as most studies were conducted over 40 years ago and have considerable risk of bias. </p> </section> <h3 class="title" id="CD003176-sec-0081">Implications for research</h3> <section id="CD003176-sec-0081"> <p>Available studies have not established the efficacy of corticosteroids, intravenous immunoglobulins and aspirin. No published randomised controlled trials have examined anti‐inflammatory treatment for acute rheumatic fever since 2001 (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). Therefore a randomised controlled trial must be undertaken to compare aspirin and other non‐steroidal anti‐inflammatory agents versus placebo. Once the effectiveness of aspirin has been established, comparison with corticosteroids becomes relevant. Further randomised placebo‐controlled trials examining the more commonly used corticosteroids (e.g. prednisone, intravenous methylprednisolone) are warranted to establish whether any net benefit is obtained when these drugs are used. The availability and use of echocardiography and other newer technologies in future randomised controlled trials will assist greatly in providing more precise, valid and objective assessment of changes in cardiac lesions. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003176-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003176-sec-0015"></div> <section id="CD003176-sec-0016"> <h3 class="title" id="CD003176-sec-0016">Pathogenesis</h3> <p>Rheumatic fever is a delayed complication of pharyngeal infection with group A beta‐haemolytic streptococci. Infection with this organism results in a diffuse inflammatory disease of the heart, joints, brain, blood vessels and subcutaneous tissue. Carditis is not seen at the time of the streptococcal infection and appears only after a latent period of about three weeks. This serves as evidence against the direct role of streptococcal products in the pathogenesis of rheumatic fever. This latent period parallels the time required for development of an immune response (<a href="./references#CD003176-bbs2-0035" title="AbrahamMT , CherianG . Cardiology. In: ChatterjeeK editor(s). An Illustrated Text/Reference. New York: Gower Medical Publishing, 1991:10.98‐10.116. ">Abraham 1991</a>). The molecular mimicry between certain parts of the streptococcus and tissues of the host may lead to a cross‐reactive immunity, in which the immune system produces an antibody response to various components of the streptococcal organism, as well as to certain tissues of the patient, particularly the heart. Immunological hyper‐responsiveness in some patients, together with disturbed helper and suppressor T‐cell function, leads to a complex immune system disturbance, which results in acute rheumatic fever and consequent cardiac damage (<a href="./references#CD003176-bbs2-0067" title="WilliamsRCJr , RaizadaV , PrakashK , van deRijnI , ZabriskieJB , StoboJD , et al. Changes in T lymphocyte subsets during acute rheumatic fever. Journal of Clinical Immunology1982;3:166‐72. ">Williams 1982</a>). Further evidence of an immunological mechanism for the pathogenesis of acute rheumatic fever is found in the presence of myocardial and endocardial deposits of immunoglobulin and complement in these patients (<a href="./references#CD003176-bbs2-0051" title="KaplanMH , BolandeR , RakitaL , BlairJ . Presence of bound immunoglobulin and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. New England Journal of Medicine1964;271:637‐45. ">Kaplan 1964</a>). In addition, rabbit antisera against certain group A streptococci have been shown to react with human heart preparations, indicating cross‐reaction between the streptococcus and the human heart (<a href="./references#CD003176-bbs2-0050" title="KaplanMH , SuchyML . Immunologic relation of streptococcal and tissue antigens: I. Properties of an antigen in certain strains of group A streptococci exhibiting an immunologic cross reaction with human heart tissue. Journal of Immunology1963;90:595. ">Kaplan 1963</a>). More recently, the pathogenic role of inflammatory cytokines in rheumatic fever in the form of tumour necrosis factor (TNF)‐alpha, interleukin (IL)‐8 and IL‐6 has been described (<a href="./references#CD003176-bbs2-0068" title="YeginO , CoskunM , ErtugH . Cytokines in acute rheumatic fever. European Journal of Pediatrics1997;156:25‐9. ">Yegin 1997</a>). Substantial evidence pointing to the inflammatory nature of the disease has resulted in use of anti‐inflammatory agents such as corticosteroids and aspirin to treat the disease. Newer therapies such as intravenous immunoglobulin (IVIG) and pentoxifylline have been used to modulate cytokine expression and suppression of activated cytotoxic T cells (<a href="./references#CD003176-bbs2-0027" title="NarinN , KarakukcuM , NarinF , AkcakusM , ErezR , HaliciC . Is pentoxifylline therapy effective for the treatment of acute rheumatic carditis?. Journal of Paediatrics and Child Health2003;39(3):214‐8. ">Narin 2003</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). </p> </section> <section id="CD003176-sec-0017"> <h3 class="title" id="CD003176-sec-0017">Predisposition and susceptibility</h3> <p>Occurrence and spread of the streptococcal organism are influenced by the age of the patient, seasonality and socio‐economic conditions. A superimposed genetic predisposition also probably exists (<a href="./references#CD003176-bbs2-0045" title="GuilhermeL , WeidebachW , KissMH , SnitcowskyR , KalilJ . Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in Brazilian population. Circulation1991;83:1995‐8. ">Guilherme 1991</a>; <a href="./references#CD003176-bbs2-0060" title="OlmezU , TurgayM , OzenirlerS , TutkakH , DuzqunN , DumanM , et al. Association of HLA class I and II antigens with rheumatic fever in Turkish population. Scandinavian Journal of Rheumatology1993;2:49‐52. ">Olmez 1993</a>). Supporting evidence for an underlying immunological susceptibility for developing acute rheumatic fever is found in the higher antibody response observed in rheumatic patients compared with non‐rheumatic individuals following administration of influenza vaccine, and the finding of isologous red blood cells in these patients (<a href="./references#CD003176-bbs2-0039" title="BarrettDJ . Pathogenesis of acute rheumatic fever. In: MajeedHA , YousofAM editor(s). Research on Cardiac and Renal Sequelae of Streptococcal Infections. Munich‐Deisenhofen: Dustri‐Verlag, 1984:32‐48. ">Barrett 1984</a>). A non‐HLA B cell antigen, known as the D8/17 lymphocyte alloantigen, has also been identified in patients with rheumatic fever (<a href="./references#CD003176-bbs2-0043" title="GangulyNK , AnandIS , KoichaM , JindalS , WahiPL . Frequency of D8/17 B lymphocyte alloantigen in north Indian patients with rheumatic heart disease. Immunology and Cell Biology1992;70:9‐14. ">Ganguly 1992</a>; <a href="./references#CD003176-bbs2-0052" title="KhannaAK , BuskirkDR , WilliamsRC , GibofskyA , CrowMK , MenonA , et al. Presence of non‐HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. Journal of Clinical Investigations1989;83(5):1710‐6. ">Khanna 1989</a>). A test to detect this B cell antigen marker can aid in the diagnosis of rheumatic fever and can help detect siblings who are at risk of developing the disease (<a href="./references#CD003176-bbs2-0047" title="HerdyGV , ZabriskieJB , ChapmanF , KhannaA , SwedoS . A rapid test for the detection of a B‐cell marker (D8/17) in rheumatic fever patients. Brazilian Journal of Medical and Biological Research1992;25(8):789‐94. ">Herdy 1992</a>). </p> </section> <section id="CD003176-sec-0018"> <h3 class="title" id="CD003176-sec-0018">Epidemiology</h3> <p>The epidemiology of acute rheumatic fever and of its complication rheumatic heart disease has changed since the first assessment of its impact, as recorded in this review for the first time in 2003. The literature at that time indicated that more than 12 million people were affected by rheumatic fever worldwide and approximately 400,000 deaths annually result from rheumatic heart disease (<a href="./references#CD003176-bbs2-0066" title="WHO/ISCF . Strategy for controlling rheumatic fever/rheumatic heart disease with emphasis on prevention: memorandum from a joint WHO/ISFC meeting. Bulletin of the World Health Organization1995;73:583‐7. ">WHO/ISCF 1995</a>). The incidence of rheumatic fever had declined in industrialised countries since the 1950s, with a recorded annual incidence of around 0.5 cases per 100,000 children of school age. A resurgence in the incidence of rheumatic fever has been reported in industrialised countries such as the intermountain area of the United States (<a href="./references#CD003176-bbs2-0065" title="VeasyLG , WiedmeierSE , OrsmondGS , RuttenbergHD , BoucekMM , RothSJ , et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. New England Journal of Medicine1987;316(8):421‐7. ">Veasy 1987</a>). In developing countries, rheumatic fever appeared to remain an endemic disease, with annual incidence ranging from 100 to 200 per 100,000 school‐aged children (<a href="./references#CD003176-bbs2-0059" title="OlivierC . Rheumatic fever ‐ is it still a problem?. Journal of Antimicrobial Chemotherapy2000;45(Suppl 13):13‐21. ">Olivier 2000</a>). In South Africa, a survey of 12,050 school children in 1972 revealed a prevalence rate of rheumatic heart disease of 6.9/1000, with a peak rate of 19.2/1000 in children aged 15 to 18 years (<a href="./references#CD003176-bbs2-0058" title="McLarenMJ , HawkinsDM , KoornhofHJ , BloomKR , Bramwell‐JonesDM , CohenE , et al. Epidemiology of rheumatic heart disease in black children of Soweto, Johannesburg. British Medical Journal1975;2:474‐7. ">McLaren 1975</a>). Rheumatic fever occurred at a much younger age in developing countries, and severe chronic valvular heart disease occurred earlier (<a href="./references#CD003176-bbs2-0046" title="HalimAM , JacquesJE . Rheumatic heart disease in the Sudan. British Heart Journal1961;23:383. ">Halim 1961</a>; <a href="./references#CD003176-bbs2-0061" title="PadmavatiS . Rheumatic fever and rheumatic heart disease in developing countries. Bulletin of the World Health Organization1978;56:543. ">Padmavati 1978</a>). The more recent estimate of the global burden of rheumatic heart disease publication in 2013 critically reviewed the previous burden of disease estimates, suggesting that very few populations worldwide have been sufficiently studied to allow for proper prevalence and incidence estimates. Nevertheless the number of definitive cases of rheumatic heart disease has been shown to remain relatively consistent in recent studies in multiple diverse populations, at a prevalence of three to eight per 1000 (<a href="./references#CD003176-bbs2-0044" title="ZuhlkeLJ , SteerAC . Estimates of the global burden of rheumatic heart disease. Global Heart2013;8(3):189‐95. ">Global Burden 2013</a>). </p> </section> <section id="CD003176-sec-0019"> <h3 class="title" id="CD003176-sec-0019">Diagnosis of rheumatic fever</h3> <p>The most commonly used criteria for the diagnosis of rheumatic fever include the modified Jones criteria (<a href="./references#CD003176-bbs2-0036" title="American Heart Association Committee to Revise the Jones' Criteria. Jones' criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation1965;32:664. ">AHA 1965</a>; <a href="./references#CD003176-bbs2-0040" title="DajaniAS , AyoubE , BiermanFZ , BisnoAL , DennyFW , DurackDT , et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Journal of the American Medical Association1992;268:2069‐73. ">Dajani 1992</a>). Diagnosis depends on the presence of events classified as major and minor manifestations of the disease. Concern about over‐diagnosis of acute rheumatic fever was the main motivation for the creation of the original Jones criteria almost 60 years ago (<a href="./references#CD003176-bbs2-0049" title="JonesTD . The diagnosis of rheumatic fever. Journal of the American Medical Association1944;126:481‐6. ">Jones 1944</a>). To increase specificity, these criteria have been revised four times ‐ in 1955, 1965, 1984 and 1992 (<a href="./references#CD003176-bbs2-0062" title="ShiffmanRN . Guideline maintenance and revision: 50 years of the Jones criteria for diagnosis of rheumatic fever. Archives of Pedatric and Adolescent Medicine1995;149:727‐32. ">Shiffman 1995</a>). The latest revision of the Jones criteria (<a href="./references#CD003176-bbs2-0040" title="DajaniAS , AyoubE , BiermanFZ , BisnoAL , DennyFW , DurackDT , et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Journal of the American Medical Association1992;268:2069‐73. ">Dajani 1992</a>) suggests that the probability of acute rheumatic fever is high when the following are found. </p> <p> <ul id="CD003176-list-0001"> <li> <p>Evidence of a preceding streptococcal infection, usually measured by elevation of the antistreptolysin O titre together with: </p> <ul id="CD003176-list-0002"> <li> <p>two major manifestations (arthritis, carditis, chorea, erythema marginatum and subcutaneous nodules); or </p> </li> <li> <p>one major and two minor manifestations (fever, arthralgia, high C‐reactive protein (CRP) or elevated erythrocyte sedimentation rate (ESR) and a prolonged PR interval on electrocardiogram). </p> </li> </ul> </li> </ul> </p> <p>CRP and ESR are also helpful for monitoring inflammatory activity in patients with acute rheumatic fever. However, the ESR does vary according to erythrocyte count and the presence of concomitant heart failure. </p> </section> <section id="CD003176-sec-0020"> <h3 class="title" id="CD003176-sec-0020">Carditis</h3> <p>Carditis, the most serious major manifestation of rheumatic fever, may culminate in chronic valvular disease and can lead to heart failure and, ultimately, death. Carditis usually has no associated symptoms and often is identified only during clinical examination of a patient who presents with fever, arthritis or chorea (involuntary, jerky movements of the limbs). Clinical features reflect involvement of various layers of the heart, viz, endocardium, including the valves, the myocardium or the pericardium, and frequently all three layers of the heart. The heart valves are the most commonly affected structures. The presence or absence of carditis is an important determinant of the course and prognosis of acute rheumatic fever. The prognosis worsens with increasing severity of the initial carditis and with recurrences (<a href="./references#CD003176-bbs2-0042" title="El‐SaidGM , El‐RefaeeMM , SorourKA , El‐SaidHG . Rheumatic fever and rheumatic heart disease. In: GarsonA , BrickerJT , FischerDJ , NeishSR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Baltimore: Williams and Wilkins, 1998:1691‐724. ">El‐Said 1998</a>). Bed rest contributes to reduced rheumatic activity (<a href="./references#CD003176-bbs2-0038" title="BarlowJB , MarcusRH , PocockWA , BarlowCW , EssopR , SareliP . Mechanisms and management of heart failure in active rheumatic carditis. South African Medical Journal1990;78:181‐6. ">Barlow 1990</a>). </p> </section> <section id="CD003176-sec-0021"> <h3 class="title" id="CD003176-sec-0021">Valvular sequelae</h3> <p>Rheumatic fever complicates untreated group A beta‐haemolytic streptococcal infection in 0.1% to 0.3% of the general population and in 3% of epidemics in closed communities (<a href="./references#CD003176-bbs2-0063" title="SiegelAC , JohnsonEE , StollermanGH . Controlled studies of streptococcal pharyngitis in a paediatric population. 1. Factors related to the attack rate of rheumatic fever. New England Journal of Medicine1961;265:559‐65. ">Siegel 1961</a>); second episode attack rates as high as 65% have been reported (<a href="./references#CD003176-bbs2-0064" title="TarantaA . Rheumatic fever in children and adolescents: a long‐term epidemiologic study of subsequent prophylaxis, streptococcal infections and clinical sequelae: IV. Relation of rheumatic fever recurrence rate per streptococcal infection to the titers of streptococcal antibodies. Annals of Internal Medicine1964;60 (Suppl 5):47. ">Taranta 1964</a>). Inflammation of components of the heart, such as the mitral and aortic valve leaflets and the chordae of the mitral valve, is the most common manifestation of rheumatic carditis (<a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a>). Recurrent attacks of rheumatic fever result in increasing damage to the valves. Damaged valves may regurgitate (fail to close properly and leak) or may become stenotic (fail to open properly). Mitral regurgitation is the most common heart defect (85%) identified in children and adolescents; it results from fibrosis and contracture of the valve leaflets, which prevents proper apposition during systole. The aortic valve is affected in 54% of patients, and the tricuspid and pulmonary valves in less than 5% (<a href="./references#CD003176-bbs2-0056" title="MarkowitzM , GordisL . Rheumatic Fever. 2nd Edition. Philadelphia: WB Saunders, 1972. ">Markowitz 1972</a>). </p> </section> <section id="CD003176-sec-0022"> <h3 class="title" id="CD003176-sec-0022">Surgery</h3> <p>Open heart surgery is needed in patients with severely regurgitant or stenotic valve lesions. Heart valves can be repaired or replaced, if deemed to be non‐repairable. Replacement of the valve with a prosthetic heart valve would require the patient to take anticoagulant treatment, usually in the form of warfarin, for life. The dosage of warfarin is crucial, and close monitoring of blood levels is needed to avoid thrombus formation on the prosthetic valve. Control of warfarin at therapeutic levels is a problem in developing countries, where many patients come from poor urban or rural settings with limited access to adequate medical care. In addition, the cost of heart surgery in patients with severely damaged valves is exorbitant and is a drain on the meagre health resources of poor countries. </p> </section> <section id="CD003176-sec-0023"> <h3 class="title" id="CD003176-sec-0023">Treatment controversies</h3> <p>Recommended therapies for acute rheumatic fever include bed rest, penicillin and anti‐inflammatory agents. </p> <section id="CD003176-sec-0024"> <h4 class="title">Steroids</h4> <p>At present, no clear consensus has been reached about the place of steroids in preventing rheumatic heart disease. Some practitioners recommend their use for patients with moderate carditis and heart failure (<a href="./references#CD003176-bbs2-0035" title="AbrahamMT , CherianG . Cardiology. In: ChatterjeeK editor(s). An Illustrated Text/Reference. New York: Gower Medical Publishing, 1991:10.98‐10.116. ">Abraham 1991</a>; <a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a>; <a href="./references#CD003176-bbs2-0042" title="El‐SaidGM , El‐RefaeeMM , SorourKA , El‐SaidHG . Rheumatic fever and rheumatic heart disease. In: GarsonA , BrickerJT , FischerDJ , NeishSR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Baltimore: Williams and Wilkins, 1998:1691‐724. ">El‐Said 1998</a>). Steroids have been shown to favourably affect clinical response while reducing the erythrocyte sedimentation rate. In addition, patients receiving steroids had a shorter hospital stay than those treated with aspirin (<a href="./references#CD003176-bbs2-0022" title="HumanDG , HillID , FraserCB . Treatment choice in acute rheumatic carditis. Archives of Disease in Childhood1984;59:410‐3. ">Human 1984</a>). Other reports suggest that heart failure in patients with active rheumatic carditis occurs as a result of a haemodynamically severe valvular lesion that can be corrected only surgically ‐ not by giving steroids (<a href="./references#CD003176-bbs2-0053" title="KingsleyRH , PocockWA . Rheumatic fever and rheumatic heart disease. In: BarlowJB editor(s). Perspectives on the Mitral Valve. Philadelphia: FA Davis, 1987:227‐45. ">Kingsley 1987</a>). Steroids are never a "lifesaving measure" in patients with a severe valvular lesion. It is argued that steroids are likely to make the tissues more friable and the task of the surgeon more difficult. Although steroids are used frequently, their use has not been shown to induce improvement in patients with fulminating rheumatic carditis (<a href="./references#CD003176-bbs2-0038" title="BarlowJB , MarcusRH , PocockWA , BarlowCW , EssopR , SareliP . Mechanisms and management of heart failure in active rheumatic carditis. South African Medical Journal1990;78:181‐6. ">Barlow 1990</a>; <a href="./references#CD003176-bbs2-0053" title="KingsleyRH , PocockWA . Rheumatic fever and rheumatic heart disease. In: BarlowJB editor(s). Perspectives on the Mitral Valve. Philadelphia: FA Davis, 1987:227‐45. ">Kingsley 1987</a>). </p> </section> <section id="CD003176-sec-0025"> <h4 class="title">Aspirin (acetylsalicylic acid)</h4> <p>Controversy surrounds the value of aspirin in patients with rheumatic fever. Data from several studies do not show an advantage of steroids over aspirin in the treatment of patients with mild or moderate carditis. It is recommended that aspirin be used in patients with mild or moderate carditis, and that steroids be reserved for patients with severe carditis, particularly those with pancarditis and cardiac failure. Use of steroids in these patients is preferred because steroids produce a more prompt anti‐inflammatory effect (<a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a>). </p> </section> </section> <section id="CD003176-sec-0026"> <h3 class="title" id="CD003176-sec-0026">Why it is important to do this review</h3> <p>Rheumatic heart disease remains a major cause of morbidity and mortality in low‐income communities (<a href="./references#CD003176-bbs2-0059" title="OlivierC . Rheumatic fever ‐ is it still a problem?. Journal of Antimicrobial Chemotherapy2000;45(Suppl 13):13‐21. ">Olivier 2000</a>). It is clear that antibiotic treatment for streptococcal pharyngitis prevents the development of rheumatic fever (<a href="./references#CD003176-bbs2-0041" title="DiSciasciaG , TarantaA . Rheumatic fever in children. American Heart Journal1980;99:635‐58. ">DiSciascia 1980</a>), and that antibiotic prophylaxis prevents recurrence (<a href="./references#CD003176-bbs2-0057" title="MassellBF , ChuteCG , WalkerAM , KurlandGS . Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. New England Journal of Medicine1988;318:280‐6. ">Massell 1988</a>). However, no consensus has been reached on the optimal management of established active carditis to prevent complications, which may include valvular heart disease and death. </p> <p>In view of the many controversies and uncertainties surrounding the use of anti‐inflammatory agents in patients with acute rheumatic fever, an up‐to‐date systematic review is indicated to clarify the most effective treatment strategy. </p> <p>A glossary of terms used throughout this review is provided in <a href="./appendices#CD003176-sec-0085">Appendix 1</a>. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003176-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003176-sec-0027"></div> <p>To assess the effects, both harmful and beneficial, of anti‐inflammatory agents such as aspirin, corticosteroids and other drugs in preventing or reducing further valvular damage in patients with acute rheumatic fever. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003176-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003176-sec-0028"></div> <section id="CD003176-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003176-sec-0030"> <h4 class="title">Types of studies</h4> <p>We included only randomised controlled trials (RCTs) in which participants were randomly assigned to receive anti‐inflammatory drugs for acute rheumatic carditis and were followed up for at least three months. We applied no language limitations. </p> </section> <section id="CD003176-sec-0031"> <h4 class="title">Types of participants</h4> <p>Trials included children and adults with a clinical diagnosis of a first or new episode of rheumatic fever, based on Jones or modified Jones criteria (<a href="./references#CD003176-bbs2-0036" title="American Heart Association Committee to Revise the Jones' Criteria. Jones' criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation1965;32:664. ">AHA 1965</a>; <a href="./references#CD003176-bbs2-0040" title="DajaniAS , AyoubE , BiermanFZ , BisnoAL , DennyFW , DurackDT , et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Journal of the American Medical Association1992;268:2069‐73. ">Dajani 1992</a>; <a href="./references#CD003176-bbs2-0049" title="JonesTD . The diagnosis of rheumatic fever. Journal of the American Medical Association1944;126:481‐6. ">Jones 1944</a>), and associated cardiac disease at the time of study enrolment. The diagnosis of cardiac disease was based on the presence of mitral and/or aortic regurgitation and/or pericarditis and/or heart failure identified by clinical examination and auscultation, or echocardiography in later studies. Participants were in‐patients, and some were subsequently followed up as out‐patients following discharge. </p> </section> <section id="CD003176-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Selected studies were those in which the following interventions were compared.</p> <p> <ul id="CD003176-list-0003"> <li> <p>Aspirin versus other anti‐inflammatory drugs or placebo.</p> </li> <li> <p>Steroids versus other anti‐inflammatory drugs or placebo.</p> </li> <li> <p>Other anti‐inflammatory drugs versus placebo.</p> </li> <li> <p>Anti‐inflammatory drugs versus no treatment.</p> </li> </ul> </p> <p>Therapy included anti‐inflammatory drugs of any type, administered by any route (i.e. intravenously, intramuscularly, orally) regardless of dosage or number of doses given. Controls included no treatment (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>), placebo infusion of dextrose and saline (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) or placebo tablets (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>). </p> </section> <section id="CD003176-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD003176-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003176-list-0004"> <li> <p>Valvular lesions developing in participants with previously normal valves.</p> </li> <li> <p>Worsening of valvular lesions in participants with valves damaged during previous attacks of rheumatic fever. </p> </li> </ul> </p> </section> <section id="CD003176-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003176-list-0005"> <li> <p>Reduction in hospital stay.</p> </li> <li> <p>Rate of decrease of erythrocyte sedimentation rate and/or C‐reactive protein.</p> </li> </ul> </p> </section> </section> </section> <section id="CD003176-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for randomised and quasi‐randomised trials related to the topic of "Anti‐inflammatory treatment of acute rheumatic fever". </p> <p>We searched the following databases for this update on 17 October 2013.</p> <p> <ul id="CD003176-list-0006"> <li> <p>The Cochrane Central Register of Controlled Trials Register (CENTRAL) (2013, Issue 9 of 12). </p> </li> <li> <p>MEDLINE (Ovid, 1948 to October Week 1 2013).</p> </li> <li> <p>EMBASE (Ovid, 1980 to 2013 Week 41).</p> </li> <li> <p>Latin American and Caribbean Health Sciences Literature (LILACS) (1982 to 17 October 2013). </p> </li> </ul> </p> <p>The following searches were not updated and were last searched in 2001 and 2011, respectively.</p> <p> <ul id="CD003176-list-0007"> <li> <p>Index Medicus (1950 to April 2001).</p> </li> <li> <p>PubMed using the terms "Rheumatic fever and treatment" (2007 to September 2011).</p> </li> </ul> </p> <p>We applied no language restrictions. We used the Cochrane sensitivity‐maximising RCT filter for MEDLINE (updated search in 2013) (<a href="./references#CD003176-bbs2-0055" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Cochrane Collaboration, 2011. ">Lefebvre 2011</a>) and an adaptation of this filer for EMBASE. See <a href="./appendices#CD003176-sec-0086">Appendix 2</a> for details of the search strategies used in 2013, <a href="./appendices#CD003176-sec-0091">Appendix 3</a> for strategies used for the 2011 update and <a href="./appendices#CD003176-sec-0096">Appendix 4</a> for the original searches conducted in 2002. </p> <p>We checked references in the identified studies.</p> </section> <section id="CD003176-sec-0037"> <h3 class="title" id="CD003176-sec-0037">Data collection and analysis</h3> <section id="CD003176-sec-0038"> <h4 class="title">Selection of studies</h4> <p>One review author (AMC) initially selected 33 papers according to relevance by reviewing titles and abstracts. Two review authors then independently analysed selected studies for predetermined inclusion criteria. We resolved disagreements regarding selection through discussion. We have undertaken three updates since initial publication of the review, and we found none of the 507 references in 2009, none of the 78 references in 2011 and none of the 816 references in 2013 to be eligible for inclusion. </p> </section> <section id="CD003176-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>We extracted various study characteristics and outcome measures, which we entered onto a predesigned data extraction form as follows. </p> <p> <ul id="CD003176-list-0008"> <li> <p>Methods: study design, method of randomisation, allocation concealment, blinding of investigators, inclusion and exclusion criteria. </p> </li> <li> <p>Population: recruitment, sample size, age, gender.</p> </li> <li> <p>Intervention: agent, dose, timing and duration of therapy, co‐interventions.</p> </li> <li> <p>Control: participants, agent and dose.</p> </li> <li> <p>Outcome: timing of outcome, reported outcomes.</p> </li> </ul> </p> <p>One review author (AMC) performed data entry and analysis and checked with a second review author. </p> </section> <section id="CD003176-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed risk of bias in the following areas using the methodology of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003176-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1 [updated March 2011]. The Cochrane Collaboration. www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>). </p> <p> <ul id="CD003176-list-0009"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective reporting.</p> </li> </ul> </p> </section> <section id="CD003176-sec-0041"> <h4 class="title">Measures of treatment effect</h4> <p>We used risk ratios (RRs) and 95% confidence intervals (CIs) as calculated for dichotomous data. </p> </section> <section id="CD003176-sec-0042"> <h4 class="title">Assessment of heterogeneity</h4> <p> <ul id="CD003176-list-0010"> <li> <p>We assessed homogeneity between studies using Chi<sup>2</sup> and I<sup>2</sup> tests. We pooled and analysed results using random‐effects models. </p> </li> <li> <p>We explored reasons for heterogeneity and the most appropriate conclusions drawn from the observations. </p> </li> </ul> </p> </section> <section id="CD003176-sec-0043"> <h4 class="title">Data synthesis</h4> <p>We pooled the data using a random‐effects model.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003176-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003176-sec-0044"></div> <section id="CD003176-sec-0045"> <h3 class="title">Description of studies</h3> <section id="CD003176-sec-0046"> <h4 class="title">Results of the search</h4> <p>One review author (AMC) initially selected 33 papers, eight of which were included for analysis. We checked a further 507 references in 2009, 78 references in 2011 and 816 references in 2013, and found that none described studies that were eligible for inclusion in the review. </p> </section> <section id="CD003176-sec-0047"> <h4 class="title">Included studies</h4> <p>We identified eight randomised controlled trials for this review. We present study details in the <a href="./references#CD003176-sec-0109" title="">Characteristics of included studies</a> table. </p> <section id="CD003176-sec-0048"> <h5 class="title">Length of trials</h5> <p>Studies provided long‐term follow‐up from one to six years.</p> </section> <section id="CD003176-sec-0049"> <h5 class="title">Participants</h5> <p>The eight included studies reported on 966 participants. All studies, except <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>, included participants with a first episode of acute rheumatic fever. Acute rheumatic fever was diagnosed according to Jones criteria 1944 (<a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>), Jones criteria 1965 (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) or Jones criteria 1992 (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). The other five studies (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>) did not state the criteria used but were not excluded from analysis, because, despite this deficiency, it is unlikely that they used criteria other than Jones or modified Jones to make a diagnosis of acute rheumatic fever. Six studies enrolled children as participants, with mean age younger than 12 years in each case (range eight to 11 years) (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a> did not indicate the age of study participants, and Stolzer (<a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>) reported on a study population that included adult male airmen only. Five of the studies were conducted in the United States (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>), one was a joint study between the United States and the United Kingdom (<a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>), one study was reported from New Zealand (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) and one from South Africa (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>). </p> </section> <section id="CD003176-sec-0050"> <h5 class="title">Inclusion criteria</h5> <p><a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> required participants to have moderate to severe carditis and time to treatment within 28 days of onset of the illness; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> and <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a> included patients with carditis and polyarthritis. Duration of aspirin treatment varied in the <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> study, depending on whether participants presented with carditis or polyarthritis; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> randomly assigned participants following a diagnosis of acute rheumatic fever and required that therapy be initiated within 18 days of onset of the illness; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a> and <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a> required participants to have a diagnosis of carditis only; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> included three groups, which consisted of participants with a normal heart, participants with carditis and those with preexisting heart disease; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a> required a diagnosis of acute rheumatic fever only. </p> </section> <section id="CD003176-sec-0051"> <h5 class="title">Study size</h5> <p><a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> was by far the largest study (497 participants), and <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a> randomly assigned only 35 participants. Three studies included between 50 and 100 participants (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>), and the remaining three studies included between 101 and 160 participants (<a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>). </p> </section> <section id="CD003176-sec-0052"> <h5 class="title">Interventions</h5> <p>Trialists provided a wide range of corticosteroid treatments, including ACTH (corticotrophin), cortisone, prednisone, dexamethasone and hydrocortisone. Dosage, route of administration, interval between symptoms and treatment and duration of treatment varied greatly. Aspirin (acetylsalicylic acid) and placebo were used as comparisons. Two studies (<a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>) examined outcomes of using ACTH and cortisone versus aspirin. <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a> combined four drugs (prednisone, dexamethasone, ACTH and cortisone) into a steroid category and compared this versus aspirin. Separate data were not provided for each drug. The study included five allocation groups. Only participants in groups 4 and 5 who were randomly assigned were included in the analysis. Non‐randomly assigned participants in groups 1, 2 and 3 who were given "no therapy", "small‐dose hormone" and "large‐dose hormone" were not included in the analysis. Prednisone was compared with aspirin in the <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> and <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> RCTs, whereas <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> chose four treatment groups, which included hydrocortisone alone, aspirin alone, hydrocortisone and aspirin together and "no specific treatment". <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a> examined the outcomes of participants given prednisone versus placebo, and <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a> studied the effects of intravenous immunoglobulin versus placebo. </p> </section> <section id="CD003176-sec-0053"> <h5 class="title">Outcomes</h5> <p>All studies provided data on long‐term follow‐up of at least one year. Chosen outcomes varied between studies. <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> included the presence of both mitral and aortic incompetence on auscultation at one year as the outcome following treatment. <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> specified cardiac outcomes as "heart disease"; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> assessed participants for the presence of apical systolic murmurs, apical diastolic murmurs and basal diastolic murmurs on auscultation; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a> determined the presence of murmurs, the need for surgery and death at follow‐up of 15 months to six years (mean three years and 11 months); <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a> assessed the presence of "signs of rheumatic heart disease at one year"; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> analysed all murmurs, including functional murmurs, present at one year. Only significant apical systolic and basal diastolic murmurs diagnosed on auscultation and detected in this study were included in the review meta‐analysis; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a> made a distinction between the presence of apical systolic, apical diastolic and aortic diastolic murmurs at 14 months, and <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a> assessed the presence of "carditis", defined by the presence of an aortic or mitral murmur diagnosed clinically, and aortic or mitral regurgitation diagnosed using echocardiography, one year after treatment. </p> <p>Multiple outcomes such as a systolic murmur at the apex and an apical diastolic murmur were documented in several participants. All cardiac outcomes, including murmurs, documented one year after treatment were grouped together as "cardiac disease" in the review meta‐analysis. Other outcomes such as ESR, CRP values and duration of hospital stay in response to anti‐inflammatory therapy were too varied and inconsistent between studies for performance of a meta‐analysis. </p> </section> <section id="CD003176-sec-0054"> <h5 class="title">Drug duration and dosage</h5> <p>Studies used not only different drugs but also various dosages and durations of therapy, for example, prednisone and aspirin were given for 12 weeks by <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; prednisone for one to two weeks and aspirin for eight weeks by <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; hydrocortisone and aspirin for 12 weeks by <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; prednisone and placebo for two to 42 days depending on clinical response by <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; ACTH, cortisone, prednisone, dexamethasone and aspirin for 12 weeks by <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; ACTH, cortisone and aspirin for five weeks by <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; cortisone, corticotrophin and aspirin for six weeks by <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>; and IVIG and placebo on four occasions over a 28‐day period by <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>. </p> <p>Oral hydrocortisone (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>) was given at a dose of 250 mg/d initially (for 96 hours) depending on whether the participant weighed more or less than 80 lb, and then at 100 mg/d × eight weeks, with subsequent tapering over three weeks. Intramuscular cortisone (<a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>) was prescribed at a dose of 300 mg/d initially (for one day) and then was tapered over six weeks. <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> treated participants with ACTH 120 USP units (for four days) and intramuscular cortisone 300 mg initially (for one day) with doses tapered over six weeks. Prednisone was given at a dose of 60 mg/d initially (for three weeks) and was tapered over nine weeks and given at 3 mg/lb for seven days by <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> and <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>, respectively. </p> </section> </section> <section id="CD003176-sec-0055"> <h4 class="title">Excluded studies</h4> <p>We initially excluded 25 studies because they were not randomised trials or did not meet the outcome analysis criteria (see <a href="./references#CD003176-sec-0110" title="">Characteristics of excluded studies</a>). We excluded two RCTs because follow‐up was provided for less than three months (<a href="./references#CD003176-bbs2-0012" title="CamaraEJN , BragaJCV , Alves‐SilvaLS , CamaraGF , daSilva LopesAA . Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiology in the Young2002;12:119‐24. ">Camara 2002</a>; <a href="./references#CD003176-bbs2-0030" title="RoweRD , McKelveyAD , KeithJD . The use of ACTH, cortisone and salicylates in the treatment of acute rheumatic fever. Canadian Medical Association Journal1953;68:15‐20. ">Rowe 1953</a>). Three were review studies (<a href="./references#CD003176-bbs2-0010" title="BywatersEGL . Treatment of rheumatic fever. Circulation1956;14:1153‐8. ">Bywaters 1956</a>; <a href="./references#CD003176-bbs2-0011" title="BywatersEGL , ThomasGT . Bed rest, salicylates and steroids in rheumatic fever. British Medical Journal1961;1:1628‐34. ">Bywaters 1961</a>; <a href="./references#CD003176-bbs2-0026" title="NaikN , BahlVK . Acute rheumatic fever: whither steroids?. Indian Heart Journal2002;54:363‐7. ">Naik 2002</a>), one was a letter (<a href="./references#CD003176-bbs2-0023" title="MarshallRL . Ibuprofen and aspirin in acute rheumatic fever. Journal of the American Medical Association1989;263(12):1633‐4. ">Marshall 1989</a>), another a retrospective analysis (<a href="./references#CD003176-bbs2-0032" title="UzielY , HashkesPJ , KassemE , PadehS , GoldmanR , VollachB . The use of naproxen in the treatment of children with rheumatic fever. The Journal of Pediatrics2000;137(2):269‐71. ">Uziel 2000</a>), one was a study on people who did not have carditis (<a href="./references#CD003176-bbs2-0029" title="PazJA , SilvaCAA , Marques‐DiasMJ . Randomized double‐blind study with prednisone in Sydenham's chorea. Pediatric Neurology2006;34:264‐9. ">Paz 2006</a>) and the remaining 17 studies examined the use of steroidal agents for treatment of acute rheumatic fever in a non‐randomised fashion. One study (<a href="./references#CD003176-bbs2-0021" title="HerdyGVH , GomesRS , SilvaAEA , SilvaLS , LopesVGS . Follow‐up of rheumatic carditis treated with steroids. Cardiology in the Young2012;22:263‐9. ">Herdy 2012</a>) met some of the search criteria regarding use of steroids in patients with rheumatic carditis, but this study was a follow‐up retrospective analysis and therefore did not meet inclusion criteria. </p> </section> </section> <section id="CD003176-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD003176-sec-0057"> <h4 class="title">Random sequence generation</h4> <p>All studies claimed to be randomised, but only one was judged to have low risk of bias (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). Six did not state how the study was randomised and were at unknown risk of bias (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>). One study included participants who were not randomly assigned and was at high risk of bias (<a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>) (<a href="#CD003176-fig-0001">Figure 1</a>; <a href="#CD003176-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD003176-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003176-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003176-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003176-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD003176-sec-0058"> <h4 class="title">Allocation concealment</h4> <p>We assessed five studies as having low risk of allocation concealment bias (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>), two as having unclear risk (<a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) and one as having high risk (<a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>) (<a href="#CD003176-fig-0001">Figure 1</a>; <a href="#CD003176-fig-0002">Figure 2</a>). </p> </section> <section id="CD003176-sec-0059"> <h4 class="title">Blinding of participants and personnel</h4> <p>Blinding of study participants was clearly described in only three studies (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>); two studies used a double‐blind design (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) and were considered to be at low risk of bias. The third study, CRFSG 1965, used both a single‐blind and and a double‐blind design and was labelled as having a high risk of bias. Three studies had unclear risk of bias (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>). Three studies were at high risk of bias: One used a consecutive single‐ and double‐blind study group (<a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>). One study (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>) specified that it was difficult for observers in this study to be unaware of group assignments because of the striking effects of corticosteroid therapy, and one included participants for which no blinding was applied (<a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>) (<a href="#CD003176-fig-0001">Figure 1</a>; <a href="#CD003176-fig-0002">Figure 2</a>). </p> <p>Three studies had low risk of detection bias (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>), two had unclear risk of detection bias (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>) and three had high risk of detection bias (<a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>) (<a href="#CD003176-fig-0001">Figure 1</a>; <a href="#CD003176-fig-0002">Figure 2</a>). </p> </section> <section id="CD003176-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>No intention‐to‐treat analysis was undertaken in any of the trials, despite small numbers of participants 'crossing over' to other treatment groups within trials (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>). Three participants in the carditis group in the <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> trial were changed from the acetylsalicylic acid (aspirin) to prednisone treatment. Four participants were moved from the aspirin group to the prednisone group in <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>. One participant was initially randomly assigned to the aspirin group and then was changed to the prednisone group because he was critically ill. Three others were changed to prednisone because they had a poor response to aspirin. One of these participants subsequently died. In <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>, five participants were moved from the aspirin group to other treatment groups (three to ACTH, two to cortisone) because of severe illness. Of these, four participants were included for analysis under their original randomisation group (aspirin), and the other was excluded from the final analysis. </p> <p>Withdrawal of participants or loss to follow‐up was well described in all studies. Between 3.2% (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) and 16% (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>) of participants withdrew from the studies, died or were lost to follow‐up. We determined that four studies were at low risk of incomplete outcome bias (<a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>). One study had unclear risk of bias (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>), two were at high risk because participants were not analysed in the groups to which they were randomly assigned (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>) and one study was at high risk because 16% of participants were lost (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>). </p> </section> <section id="CD003176-sec-0061"> <h4 class="title">Selective reporting</h4> <p>Most studies did not report outcomes in the Methods and therefore were at unclear risk of reporting bias (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>). One study was at low risk (<a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>), and one was at high risk (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) (<a href="#CD003176-fig-0001">Figure 1</a>; <a href="#CD003176-fig-0002">Figure 2</a>). </p> <p>Overall risk of bias in most studies was high or unclear for all biases except allocation concealment and incomplete outcome bias, and most studies had unclear or high risk of bias for most types of bias. </p> </section> </section> <section id="CD003176-sec-0062"> <h3 class="title" id="CD003176-sec-0062">Effects of interventions</h3> <p>We identified eight randomised controlled trials with dichotomous data describing cardiac outcomes in participants given anti‐inflammatory agents. All studies examined cardiac outcomes after at least one year. None of the studies undertook an intention‐to‐treat analysis or compared aspirin versus placebo. </p> <section id="CD003176-sec-0063"> <h4 class="title">Primary outcome ‐ cardiac disease after one year</h4> <section id="CD003176-sec-0064"> <h5 class="title">Corticosteroids versus aspirin</h5> <p>Significant statistical heterogeneity was observed between trials (I<sup>2</sup> = 69%, χ<sup>2</sup> = 16.04, df = 5, P value = 0.0062; <a href="./references#CD003176-fig-0003" title="">Analysis 1.1</a>). Anti‐inflammatory agents studied included ACTH (corticotrophin), cortisone, dexamethasone, prednisone and aspirin. Pooled analysis showed no evidence of differences between steroidal agents and aspirin in preventing cardiac outcomes (RR 0.87, 95% CI 0.66 to 1.15; <a href="./references#CD003176-fig-0003" title="">Analysis 1.1</a>). Three studies showed some benefit of steroids over aspirin (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>), with only one (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>) showing statistical significance (RR 0.43, 95% CI 0.19 to 0.97). Three studies showed higher risk of cardiac disease at one year after treatment with corticosteroids compared with aspirin (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>). One study stood out as the only study displaying some advantage for aspirin, although statistically insignificant, in reducing risk of cardiac disease compared with prednisone (RR 1.71, 95% CI 0.92 to 3.19) (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>). </p> <section id="CD003176-sec-0065"> <h6 class="title">Hydrocortisone versus aspirin</h6> <p><a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> was the sole randomised trial comparing oral hydrocortisone versus aspirin. A significant reduction in cardiac disease was reported at one year when hydrocortisone was compared with aspirin (RR 0.43, 95% CI 0.19 to 0.97). Although cardiac disease was significantly reduced with hydrocortisone, no significant difference between various treatment groups (hydrocortisone, aspirin, hydrocortisone and aspirin and no treatment) was observed in the development of new murmurs among participants with murmurs absent at the start of the study. </p> </section> <section id="CD003176-sec-0066"> <h6 class="title">Prednisone versus aspirin</h6> <p>We used in this analysis data from two studies (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>) with 212 participants. The pooled estimate showed no reduction in heart disease after one year when prednisone was used over aspirin (RR 1.13, 95% CI 0.52 to 2.45; <a href="./references#CD003176-fig-0005" title="">Analysis 2.1</a>). </p> </section> <section id="CD003176-sec-0067"> <h6 class="title">Outcomes of participants with severe disease</h6> <p>Only five studies reported outcomes in participants with severe disease characterised by a grade 3 apical systolic murmur assessed clinically (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) or by use of echocardiographic criteria (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) at the start of treatment. The number of participants with severe heart disease was small compared with the total number of participants. No evidence suggested a difference in reduction in heart disease after one year between corticosteroids and aspirin (three studies, 119 participants, RR 0.94, 95% CI 0.32 to 2.70; <a href="./references#CD003176-fig-0004" title="">Analysis 1.2</a>). Participants with severe heart disease in the <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> study failed to improve with prednisone or aspirin (risk ratio therefore was not estimable). One study in which only nine participants had severe disease showed hydrocortisone to be more beneficial in reducing the severity of cardiac disease compared with aspirin after one year (RR 0.17, 95% CI 0.03 to 1.00) (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>). The study with the greatest number of participants with severe disease (n = 89) found no statistically significant benefit for corticosteroid therapy compared with aspirin (RR 2.16, 95% Cl 0.97 to 4.81) (<a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>). </p> </section> </section> <section id="CD003176-sec-0068"> <h5 class="title">Prednisone and intravenous immunoglobulin (IVIG) versus placebo</h5> <p>Effects of the two study medications were assessed separately. The benefit of using IVIG (<a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>) (RR 0.87, 95% CI 0.55 to 1.39) or prednisone (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>) (RR 1.78, 95% CI 0.95 to 3.34) over placebo to prevent cardiac disease in patients with acute rheumatic fever was not statistically significant. </p> <section id="CD003176-sec-0069"> <h6 class="title">Outcome of severe disease</h6> <p>Two studies confirmed that the effects of prednisone (RR 2.5, 95% Cl 0.42 to 14.83) or IVIG (RR 0.79, 95% Cl 0.31 to 1.96) were similar to those of placebo for participants with severe valvular disease (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). </p> </section> </section> </section> <section id="CD003176-sec-0070"> <h4 class="title">Secondary outcomes</h4> <p>Outcomes such as reduction in hospital stay, erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP) were not reported by <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> and <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>. <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> reported similar ESR levels in the prednisone and salicylate groups. <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> graphically depicted a prompt and striking drop in ESR with the use of hydrocortisone, which increased upon withdrawal of therapy. Aspirin also had a striking effect on ESR, but not as marked as that of hydrocortisone. <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a> found ESR, CRP and sleeping pulse responses to be similar in prednisone and placebo groups. <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> showed a more dramatic drop in ESR in the corticosteroid groups compared with the aspirin groups, but this increased sharply, although temporarily, in both corticosteroid groups after treatment was stopped, in contrast to a negligible change in the aspirin group. ESR eventually reached a similarly low level in all three groups at 13 weeks, and this level was maintained at one year. Corticotrophin had the most marked effect on reducing ESR compared with cortisone and aspirin in the <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a> trial. <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a> demonstrated that ESR measurements in the IVIG and placebo groups were similar at six weeks following the intervention. However, a significant difference was noted at one week and two weeks, with ESR significantly higher in the IVIG group. </p> </section> <section id="CD003176-sec-0071"> <h4 class="title">Adverse effects of study drugs</h4> <p>Complications related to trial medication were not disclosed in five studies (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). Untoward reactions were reported in the remaining three trials. <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a> noted steroidal effects such as weight gain, moon face, buffalo hump, striae of the skin and acne. <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a> found that ACTH and cortisone groups had similar steroidal effects. Participants in the aspirin group experienced tinnitus, deafness, nausea and hyperventilation. <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> reported symptoms of nausea, emesis and tinnitus in some participants receiving aspirin. Two participants receiving hydrocortisone and aspirin developed gastric ulceration. </p> </section> <section id="CD003176-sec-0072"> <h4 class="title">Concomitant therapy</h4> <p>Concomitant treatments were very similar in these trials. Bed rest, penicillin for 10 days, prophylactic antibiotics after 10 days, diuretics and digitalis (for heart failure) constituted standard auxiliary therapy in five studies (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). Bed rest may be an important co‐factor in the success of corticosteroid therapy. Although penicillin prophylaxis was provided in the <a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a> study, bed rest was not reported as part of the treatment regimen. Supplementary treatment was not indicated by <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a> and <a href="./references#CD003176-bbs2-0005" title="MassellBF , JhaveriS , CzoniczerG , BarnetR . Treatment of rheumatic fever and rheumatic carditis. observations providing a basis for the selection of aspirin or adrenocortical steroids. Medical Clinics of North America1961;45:1349‐68. ">Massell 1961</a>. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003176-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003176-sec-0073"></div> <section id="CD003176-sec-0074"> <h3 class="title" id="CD003176-sec-0074">Summary of main results</h3> <p>None of the included trials showed consistent benefit with the use of corticosteroids, aspirin or IVIG in ameliorating or avoiding cardiac disease one year after treatment among participants with acute rheumatic fever. The combined analysis of corticosteroid agents ACTH, cortisone, prednisone, dexamethasone and hydrocortisone indicated a weak overall favourable outcome in preventing cardiac disease compared with aspirin (random risk ratio 0.87, 95% confidence interval 0.66 to 1.15). Thus, the data do not provide sufficient quantitative evidence to support the use of corticosteroid therapy, IVIG or aspirin to prevent cardiac disease in patients with acute rheumatic fever, if they offer no compelling reason for selection of corticosteroids over aspirin or vice versa. </p> </section> <section id="CD003176-sec-0075"> <h3 class="title" id="CD003176-sec-0075">Overall completeness and applicability of evidence</h3> <p>Both studies comparing anti‐inflammatory agents, oral prednisone and IVIG versus placebo identified no benefit from the use of active agents (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0008" title="VossLM , WilsonNJ , NeutzeJM , WhitlockRML , AmeratungaRV , CairnsLM , et al. A randomized controlled trial of intravenous immunoglobulin in acute rheumatic fever. Circulation2001;103(3):401‐6. ">Voss 2001</a>). </p> <p>Two smaller studies (<a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>; <a href="./references#CD003176-bbs2-0007" title="StolzerBL , HouserHB , ClarkEJ . Therapeutic agents in rheumatic carditis. Comparative effects of acetylsalicylic acid, corticotrophin, and cortisone. Archives of Internal Medicine1955;95:677‐88. ">Stolzer 1955</a>) stood out because they confirmed benefit derived from the use of oral hydrocortisone and intramuscular cortisone, respectively, in preventing cardiac disease compared with aspirin. However, in the light of the absence of evidence of efficacy of aspirin (no trial comparing aspirin with placebo), the significance of these results is unknown. </p> </section> <section id="CD003176-sec-0076"> <h3 class="title" id="CD003176-sec-0076">Quality of the evidence</h3> <p>Type, dose and duration of corticosteroids and other medications varied between studies. Differences in outcomes between prednisone and hydrocortisone may be explained by the fact that prednisone is a less effective agent than hydrocortisone, or that corticosteroids need to be given for a longer period (12 weeks) to be effective, as was the case in the <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> study. </p> <p>In at least three of the trials (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0002" title="Combined Rheumatic Fever Study Group. Baltimore and New York City. A comparison of short‐term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. New England Journal of Medicine1965;272:63‐70. ">CRFSG 1965</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>), participants 'crossed over' from one intervention to another. However, the meta‐analysis was performed by using the original randomisation groups in an attempt to adhere to 'intention‐to‐treat' principles. </p> <p>Only five studies included participants with severe cardiac disease and documented outcomes following treatment with steroidal agents, IVIG or aspirin. Overall 152 participants were included in this subanalysis of only data from <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a>, and the fewest participants (n = 9) showed a statistical beneficial outcome following administration of oral hydrocortisone. The inclusion criteria of <a href="./references#CD003176-bbs2-0003" title="DorfmanA , GrossJI , LorinczAE . The treatment of acute rheumatic fever. Pediatrics1961;27:692‐706. ">Dorfman 1961</a> did not include carditis, but methods of selection and assignment of cases appear to have resulted in satisfactory random assignment of participants with carditis to each group. Other severe outcomes such as death and the requirement for heart surgery were reported in only three studies (<a href="./references#CD003176-bbs2-0001" title="Combined Rheumatic Fever Study Group. New York City, Baltimore , Boston , Cleveland . A comparison of the effect of prednisone and acetylsalicylic acid on the incidence of residual rheumatic heart disease. New England Journal of Medicine1960;262:895‐902. ">CRFSG 1960</a>; <a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>; <a href="./references#CD003176-bbs2-0006" title="A joint report by the Rheumatic Fever Working Party of the Medical Research Council of Great Britain and the Subcommittee of Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. The treatment of acute rheumatic fever in children. A cooperative clinical trial of ACTH, cortisone and aspirin. Circulation1955;11:343‐71. ">RFWP 1955</a>). Investigators reported a total of eight deaths and five participants requiring surgery, with five deaths and four surgical interventions occurring in the corticosteroid group. The data refute a life‐saving role for corticosteroid therapy in patients with rheumatic carditis. </p> <p>Secondary objectives of this review were to evaluate the effects of anti‐inflammatory treatment on hospital stay and on erythrocyte sedimentation rate and C‐reactive protein values. Reporting of these outcomes was too varied and inconsistent for adequate analysis. Corticosteroids appeared superior to aspirin in the rate at which ESR drops. However, this is not a compelling reason to choose one drug over another, as the significance of this rapid fall is not defined. </p> <p>Five studies did not report on adverse events. The three studies that did so noted steroidal effects such as weight gain, moon face, buffalo hump, striae of the skin and acne and gastric ulceration. Participants in the aspirin group experienced tinnitus, deafness, nausea and hyperventilation. </p> </section> <section id="CD003176-sec-0077"> <h3 class="title" id="CD003176-sec-0077">Potential biases in the review process</h3> <p>Limitations of the review process and potential sources of bias in this review include lack of intention‐to‐treat analyses in the original studies, along with antiquated studies and the small number of trials available for analysis. Statistical heterogeneity between studies was significant. Major differences between studies were noted regarding patient diagnosis, inclusion criteria, interventions (various types, doses used, duration), outcomes (mainly type of outcome, such as systolic murmurs, diastolic murmurs and "carditis") and methodology, such as lack of blinding in some studies. For all these reasons, results should be interpreted with caution. </p> </section> <section id="CD003176-sec-0078"> <h3 class="title" id="CD003176-sec-0078">Agreements and disagreements with other studies or reviews</h3> <p>Prednisone continues to be recommended in contemporary reference textbooks for patients with carditis and acute rheumatic fever (<a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a>; <a href="./references#CD003176-bbs2-0042" title="El‐SaidGM , El‐RefaeeMM , SorourKA , El‐SaidHG . Rheumatic fever and rheumatic heart disease. In: GarsonA , BrickerJT , FischerDJ , NeishSR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Baltimore: Williams and Wilkins, 1998:1691‐724. ">El‐Said 1998</a>). The recommended duration of steroid treatment differs from that used in the studies mentioned above, for example, <a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a> suggests 2 mg/kg/d of prednisone for two weeks followed by gradual withdrawal over the following two weeks, and <a href="./references#CD003176-bbs2-0042" title="El‐SaidGM , El‐RefaeeMM , SorourKA , El‐SaidHG . Rheumatic fever and rheumatic heart disease. In: GarsonA , BrickerJT , FischerDJ , NeishSR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Baltimore: Williams and Wilkins, 1998:1691‐724. ">El‐Said 1998</a> recommends 2 mg/kg/d of prednisone or prednisolone for three to four weeks. In addition, <a href="./references#CD003176-bbs2-0037" title="AyoubEM . Acute rheumatic fever. In: EmmanouilidesGC , RiemenschneiderTA , AllenHD , GutgesellHP editor(s). Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and the Young Adult. 5th Edition. Baltimore: Williams and Wilkinson, 1995:1400‐16. ">Ayoub 1995</a> suggests that aspirin should be used in patients with carditis for four to eight weeks at a dose of 90 to 100 mg/kg/d, depending on clinical response. A more recent review (<a href="./references#CD003176-bbs2-0054" title="KumarRK , TandonR . Rheumatic fever and rheumatic heart disease: the last 50 years. Indian Journal of Medical Research2013;137:643‐58. ">Kumar 2013</a>) indicates that no significant change has been reported in the management of acute rheumatic fever over the past 50 years, and suggests that anti‐inflammatory agents such as aspirin and steroids, although they continue to be used to control rheumatic activity, do not cure rheumatic fever. The evidence base for these recommendations is clearly lacking. </p> <p>Rheumatic fever and its valvular heart disease sequelae continue to be major causes of acquired heart disease in developing countries. Despite this, only one study was carried out in a developing country (<a href="./references#CD003176-bbs2-0004" title="HaffejeeIE , MoosaA . A double‐blind placebo‐controlled trial of prednisone in active rheumatic carditis. Annals of Tropical Paediatrics1990;10:395‐400. ">Haffejee 1990</a>), and the remaining seven studies took place in the USA, the United Kingdom and New Zealand. The number of randomised controlled trials examining treatment of acute rheumatic fever has diminished since the 1950s and 1960s in tandem with the decrease in prevalence of rheumatic heart disease in developed countries. The relevance and applicability to the current situation of data derived from studies performed 35 to 50 years ago in poorer countries remain pertinent because of the high incidence of rheumatic fever reported in industrialised countries during that period (<a href="./references#CD003176-bbs2-0059" title="OlivierC . Rheumatic fever ‐ is it still a problem?. Journal of Antimicrobial Chemotherapy2000;45(Suppl 13):13‐21. ">Olivier 2000</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003176-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/urn:x-wiley:14651858:media:CD003176:CD003176-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_t/tCD003176-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003176-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003176-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/urn:x-wiley:14651858:media:CD003176:CD003176-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_t/tCD003176-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003176-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/full#CD003176-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003176-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/urn:x-wiley:14651858:media:CD003176:CD003176-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_t/tCD003176-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus aspirin, Outcome 1 Cardiac disease after 1 year." data-id="CD003176-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus aspirin, Outcome 1 Cardiac disease after 1 year.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#CD003176-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003176-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/urn:x-wiley:14651858:media:CD003176:CD003176-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_t/tCD003176-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Corticosteroids versus aspirin, Outcome 2 Outcome of severe cardiac disease after 1 year." data-id="CD003176-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Corticosteroids versus aspirin, Outcome 2 Outcome of severe cardiac disease after 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#CD003176-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003176-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/urn:x-wiley:14651858:media:CD003176:CD003176-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_t/tCD003176-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Individual corticosteroids versus aspirin, Outcome 1 Cardiac disease after 1 year." data-id="CD003176-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Individual corticosteroids versus aspirin, Outcome 1 Cardiac disease after 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#CD003176-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/media/CDSR/CD003176/image_n/nCD003176-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD003176-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus aspirin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cardiac disease after 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.66, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Outcome of severe cardiac disease after 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.32, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Corticosteroids versus aspirin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#CD003176-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003176-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Individual corticosteroids versus aspirin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cardiac disease after 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.42, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Hydrocortisone versus aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.19, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Prednisone versus aspirin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.52, 2.45]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Individual corticosteroids versus aspirin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003176.pub3/references#CD003176-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003176.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD003176-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD003176-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003176-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD003176-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD003176-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD003176-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003176\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003176\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003176\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003176\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003176\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003176.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003176.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003176.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003176.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003176.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724660463"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003176.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724660466"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003176.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e68428bc01c00',t:'MTc0MDcyNDY2MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 